These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 20863722)
21. Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Ashida S; Okuda H; Chikazawa M; Tanimura M; Sugita O; Yamamoto Y; Nakamura S; Moriyama M; Shuin T Clin Cancer Res; 2000 Oct; 6(10):3817-22. PubMed ID: 11051223 [TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma. Igarashi H; Esumi M; Ishida H; Okada K Cancer; 2002 Jul; 95(1):47-53. PubMed ID: 12115316 [TBL] [Abstract][Full Text] [Related]
23. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184 [TBL] [Abstract][Full Text] [Related]
24. Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis. Inoue H; Nonomura N; Kojima Y; Shiba M; Oka D; Arai Y; Nakayama M; Takayama H; Nishimura K; Mori H; Okuyama A Nephrol Dial Transplant; 2007 Jul; 22(7):2052-5. PubMed ID: 17438007 [TBL] [Abstract][Full Text] [Related]
25. Identification of somatic mutations in the von Hippel-Lindau (VHL) gene in a patient with renal cell carcinoma. Wang WC; Chen HJ; Tseng YH; Lai YC J Formos Med Assoc; 2009 Nov; 108(11):886-93. PubMed ID: 19933033 [TBL] [Abstract][Full Text] [Related]
26. Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study. Schouten LJ; van Dijk BA; Oosterwijk E; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Schalken JA; van den Brandt PA J Hypertens; 2005 Nov; 23(11):1997-2004. PubMed ID: 16208141 [TBL] [Abstract][Full Text] [Related]
27. [Frequent somatic mutations of the von Hippel-Lindau tumor suppressor gene in primary sporadic human renal clear cell carcinomas]. Gong K; Zhang Z; Xin D Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(3):142-4. PubMed ID: 11798864 [TBL] [Abstract][Full Text] [Related]
28. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493 [TBL] [Abstract][Full Text] [Related]
29. [Correlation of cyclin D1 overexpression to mutations of von hippel-lindau gene in renal clear cell carcinoma]. Ren YY; Du LJ; Feng ZQ; Leng J Ai Zheng; 2006 Feb; 25(2):175-8. PubMed ID: 16480581 [TBL] [Abstract][Full Text] [Related]
30. [Somatic mutations of VHL gene and HIF-1alpha expression in primary renal clear cell carcinomas]. Guo HF; Gong K; Zou SM; Zhang ZW; Liu XY; Na X; Wu G; Na YQ Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(4):196-200. PubMed ID: 15062033 [TBL] [Abstract][Full Text] [Related]
31. EGFR and K-ras mutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens. Gallegos Ruiz MI; Floor K; Rijmen F; Grünberg K; Rodriguez JA; Giaccone G Cell Oncol; 2007; 29(3):257-64. PubMed ID: 17452778 [TBL] [Abstract][Full Text] [Related]
32. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Banks RE; Tirukonda P; Taylor C; Hornigold N; Astuti D; Cohen D; Maher ER; Stanley AJ; Harnden P; Joyce A; Knowles M; Selby PJ Cancer Res; 2006 Feb; 66(4):2000-11. PubMed ID: 16488999 [TBL] [Abstract][Full Text] [Related]
34. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma. Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414 [TBL] [Abstract][Full Text] [Related]
35. Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: observations on DNA, RNA, protein extractions and VHL mutation detection. Kurban G; Gallie BL; Leveridge M; Evans A; Rushlow D; Matevski D; Gupta R; Finelli A; Jewett MA Pathol Res Pract; 2012 Jan; 208(1):22-31. PubMed ID: 22177731 [TBL] [Abstract][Full Text] [Related]
36. Novel mutations of the von hippel-lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell type. Meyer AJ; Hernandez A; Florl AR; Enczmann J; Gerharz CD; Schulz WA; Wernet P; Ackermann R Int J Cancer; 2000 Sep; 87(5):650-3. PubMed ID: 10925357 [TBL] [Abstract][Full Text] [Related]
37. Mutations in the VHL gene from potassium bromate-induced rat clear cell renal tumors. Shiao YH; Kamata SI; Li LM; Hooth MJ; DeAngelo AB; Anderson LM; Wolf DC Cancer Lett; 2002 Dec; 187(1-2):207-14. PubMed ID: 12359370 [TBL] [Abstract][Full Text] [Related]
38. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1). Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559 [TBL] [Abstract][Full Text] [Related]